Restart Life Sciences Corp. (CSE:HEAL)

Canada flag Canada · Delayed Price · Currency is CAD
0.1100
-0.0100 (-8.33%)
Jan 19, 2026, 1:14 PM EST
83.33%
Market Cap5.87M
Revenue (ttm)n/a
Net Income (ttm)-1.23M
Shares Out53.32M
EPS (ttm)-0.05
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,112
Average Volume45,362
Open0.1100
Previous Close0.1200
Day's Range0.1100 - 0.1100
52-Week Range0.0400 - 0.1750
Beta-1.03
RSI54.26
Earnings DateApr 8, 2026

About Restart Life Sciences

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol HEAL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.